GLP-1 (Semaglutide) vs. Tesamorelin

When evaluating GLP-1 (Semaglutide) versus Tesamorelin for biological age reduction, the primary consideration is the specific hallmark of aging being targeted. While both compounds offer systemic healthspan benefits, their mechanisms of action are distinct.

When to prioritize GLP-1 (Semaglutide):

Select GLP-1 (Semaglutide) when the primary clinical objective aligns with its core mechanism: glp-1 receptor agonist that delays gastric emptying and activates hypothalamic satiety centers to suppress appetite.. This is particularly relevant for protocols focused on significant weight loss via appetite suppression and metabolic improvement..

When to prioritize Tesamorelin:

Conversely, Tesamorelin is the superior choice when targeting ghrh analog that stimulates pituitary gh release, leading to igf-1 elevation and visceral fat reduction., making it the preferred agent for visceral fat reduction and gh stimulation..